GlassScriptPhysician profile
Haidy Rivero
NPI 1346662947
$2,550.99
in general payments reported to CMS, 2019-2025
26 companies · $941 in 2025
The $941 reported for 2025 was more than what 89% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $524 · 2021: $213 · 2022: $40.35 · 2023: $59.02 · 2024: $67.76 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $674.49 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $330.90 | 2019-2025 | Evenity |
| Amarin Pharma, INC. | $177.48 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $170.38 | 2019 | |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Arexvy |
| Janssen Pharmaceuticals, INC | $124.93 | 2019 | |
| Redhill Biopharma INC. | $109.38 | 2020-2021 | |
| Horizon Therapeutics Plc | $104.63 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $96.11 | 2024-2025 | |
| Fidia Pharma USA INC. | $71.62 | 2024-2025 | Triluron, Hymovis, Hyalgan |
| Lilly USA, LLC | $71.28 | 2020-2021 | |
| Abbvie INC. | $62.50 | 2025 | |
| Pfizer INC. | $55.66 | 2021-2023 | |
| Medtronic, INC. | $53.44 | 2024-2025 | Minimed 780g, Percept PC Brainsense |
| Axogen | $48.58 | 2022-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $37.67 | 2025 | Standard Rf Disposables |
| Exact Sciences Corporation | $30.17 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.58 | 2020 | |
| Linvatec Corporation | $28.31 | 2025 | Linvatec Arthroscopy |
| Ebi, LLC | $26.31 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $26.31 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Shield Therapeutics INC | $24.55 | 2025 | |
| Endo Pharmaceuticals INC. | $22.88 | 2020 | |
| Daiichi Sankyo INC. | $18.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.83 | 2020 | |
| Smith+Nephew, INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haidy Rivero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.